US Obesity Rates Decline Amid Rise in Weight-Loss Drug Use

For the first time in over a decade, U.S. obesity rates have slightly decreased, from 46% in 2022 to 45.6% in 2023, potentially due to the increased use of weight loss medications like semaglutide. A study in JAMA Health Forum highlights this trend, noting significant declines among women and older adults, particularly in the South where these drugs are widely used. While the findings are promising, experts caution that it's too early to determine if this trend will continue, emphasizing the importance of combining weight loss with lifestyle changes for overall health improvement.